Araştırma Makalesi
BibTex RIS Kaynak Göster
Yıl 2023, Cilt: 6 Sayı: 2, 294 - 299, 27.03.2023
https://doi.org/10.32322/jhsm.1226744

Öz

Kaynakça

  • Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease–a systematic review and meta-analysis. PloS one 2016; 11: e0158765..
  • London GM, Safar ME, Pannier B: Aortic aging in ESRD: structural, hemodynamic, and mortality implications. J Am Soc Nephrol 2016; 27: 1837-46.
  • Mathew RO, Bangalore S, Lavelle MP, et al. Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review. Kidney Int 2017; 91: 797-807.
  • Saran R, Li Y, Robinson B, et al. US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis 2016; 67: Svii S1-305.
  • Ford ML, Tomlinson LA, Chapman TP, Rajkumar C, Holt SG. Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4. Hypertension 2010; 55: 1110-5.
  • Taal MW: Arterial stiffness in chronic kidney disease: an update. Current Opinion in Nephrology and Hypertension 2014; 23: 169-73.
  • Baykara M, Demirel A, Yavuzatmaca I, Bilgen M. Response of arterial stiffness four weeks after terminating short‐term aerobic exercise training in a sedentary lifestyle. J Ultrasound Med 2017; 36: 353-9.
  • Bansal N: Evolution of cardiovascular disease during the transition to end-stage renal disease. In: Seminars in Nephrology, Elsevier 2017: 120-31.
  • Dalrymple LS, Katz R, Kestenbaum B, et al. Chronic kidney disease and the risk of end-stage renal disease versus death. J General Int Med 2011; 26: 379-385.
  • Matsushita K, Van der Velde M, Astor B, et al. Chronic Kidney Disease Prognosis Consortium: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073-81.
  • Tonelli M, Muntner P, Lloyd A, et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet 2012; 380: 807-14.
  • Yerram P, Karuparthi PR, Hesemann L, Horst J, Whaley-Connell A. Chronic kidney disease and cardiovascular risk. J Am Soc Hypertens 2007; 1: 178-84.
  • Khamdaeng T, Luo J, Vappou J, Terdtoon P, Konofagou E. Arterial stiffness identification of the human carotid artery using the stress–strain relationship in vivo. Ultrasonics 2012; 52: 402-11.
  • Townsend RR: Arterial stiffness in CKD: a review. Am J Kidney Dis 2019; 73: 240-7.
  • Alani H, Tamimi A, Tamimi N. Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs. World J Nephrol 2014; 3: 156-68.
  • Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55: 1318-27.
  • Salvi P, Parati G. Arterial stiffness and renal function—a complex relationship. Nat Rev Nephrol 2015; 11: 11-3.
  • Mitchell GF. Arterial stiffness and hypertension. Hypertension 2014; 64: 13-8.
  • Vlachopoulos C, Xaplanteris P, Aboyans V, et al. The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. Atherosclerosis 2015; 241: 507-32.
  • Zanoli L, Empana J-P, Perier M-C, et al. Increased carotid stiffness and remodelling at early stages of chronic kidney disease. J Hypertens 2019; 37: 1176-82.
  • Nemcsik J, Kiss I, Tislér A. Arterial stiffness, vascular calcification and bone metabolism in chronic kidney disease. World J Nephrol 2012; 1: 25.
  • McIntyre NJ, Fluck RJ, McIntyre CW, Fakis A, Taal MW. Determinants of arterial stiffness in chronic kidney disease stage 3. PLoS One 2013; 8: e55444.
  • Verhave JC, Fesler P, Du Cailar G, Ribstein J, Safar ME, Mimran A. Elevated pulse pressure is associated with low renal function in elderly patients with isolated systolic hypertension. Hypertension 2005; 45: 586-91.
  • Cesana F, Giannattasio C, Nava S, et al. Impact of blood glucose variability on carotid artery intima media thickness and distensibility in type 1 diabetes mellitus. Blood Pressure 2013; 22: 355-61.
  • Baykara S, Bozdağ PG, Baykara M, Namlı MN. Evaluation of arterial stiffness in patients with schizophrenia. J Clin Neurosci 2020; 79: 149-53.
  • Sarıca MA, İmam S. Cilostazol decreased carotid arterial stiffness and increased vertebral arterial flows in patient with peripheral arterial. Ann Vasc Med Res 2016; 3: 1034.

A comparative study of the effects of chronic kidney disease on sonographic arterial stiffness parameters in geriatric and normal population

Yıl 2023, Cilt: 6 Sayı: 2, 294 - 299, 27.03.2023
https://doi.org/10.32322/jhsm.1226744

Öz

Aim: Due to its growing incidence rate worldwide, chronic kidney disease is a crucial public health problem which is strongly associated with cardiovascular disease. Cardiovascular disease in chronic kidney disease patients is characterized by arteriosclerosis and increased arterial stiffness, and is the leading cause of morbidity and mortality. A correlation was reported between an increased arterial stiffness and cardiovascular disease in high risk groups such as chronic kidney disease or hypertension as well as general undiagnosed population. Our aim was to show the changes in arterial stiffness parameters in patients with chronic kidney disease in the geriatric population.
Material and Method: 44 chronic kidney disease patients and 44 control group cases of the same age were included in the study. There were 20 female and 24 male cases in each group. Systolic and diastolic diameter were measured for all cases. Intima-media thickness was measured in carotid and femoral arteries. Arterial stiffness parameters were calculated using formulas. Systolic and diastolic arterial blood pressure and body mass index were measured. Their urea and creatinine values were recorded.
Results: There were no differences between two groups in terms of age and sex (p=0.069). Body mass index in the patient group was significantly lower compared to the control group (p=0.025). Systolic arterial blood pressure was higher in the patient group (p<0.001). Arterial stiffness parameters in both arterial systems, particularly in femoral artery, were significantly (p<0.05) worse in the patient group compared to the control group.
Conclusion: Intima-media thickness was measured higher, which overlaps with the existing literature. Femoral parameters were more effective in the prediction of atherosclerosis. Chronic kidney disease affects cardiovascular system negatively, and increases atherosclerosis significantly compared to the normal population.

Kaynakça

  • Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease–a systematic review and meta-analysis. PloS one 2016; 11: e0158765..
  • London GM, Safar ME, Pannier B: Aortic aging in ESRD: structural, hemodynamic, and mortality implications. J Am Soc Nephrol 2016; 27: 1837-46.
  • Mathew RO, Bangalore S, Lavelle MP, et al. Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review. Kidney Int 2017; 91: 797-807.
  • Saran R, Li Y, Robinson B, et al. US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis 2016; 67: Svii S1-305.
  • Ford ML, Tomlinson LA, Chapman TP, Rajkumar C, Holt SG. Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4. Hypertension 2010; 55: 1110-5.
  • Taal MW: Arterial stiffness in chronic kidney disease: an update. Current Opinion in Nephrology and Hypertension 2014; 23: 169-73.
  • Baykara M, Demirel A, Yavuzatmaca I, Bilgen M. Response of arterial stiffness four weeks after terminating short‐term aerobic exercise training in a sedentary lifestyle. J Ultrasound Med 2017; 36: 353-9.
  • Bansal N: Evolution of cardiovascular disease during the transition to end-stage renal disease. In: Seminars in Nephrology, Elsevier 2017: 120-31.
  • Dalrymple LS, Katz R, Kestenbaum B, et al. Chronic kidney disease and the risk of end-stage renal disease versus death. J General Int Med 2011; 26: 379-385.
  • Matsushita K, Van der Velde M, Astor B, et al. Chronic Kidney Disease Prognosis Consortium: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073-81.
  • Tonelli M, Muntner P, Lloyd A, et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet 2012; 380: 807-14.
  • Yerram P, Karuparthi PR, Hesemann L, Horst J, Whaley-Connell A. Chronic kidney disease and cardiovascular risk. J Am Soc Hypertens 2007; 1: 178-84.
  • Khamdaeng T, Luo J, Vappou J, Terdtoon P, Konofagou E. Arterial stiffness identification of the human carotid artery using the stress–strain relationship in vivo. Ultrasonics 2012; 52: 402-11.
  • Townsend RR: Arterial stiffness in CKD: a review. Am J Kidney Dis 2019; 73: 240-7.
  • Alani H, Tamimi A, Tamimi N. Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs. World J Nephrol 2014; 3: 156-68.
  • Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55: 1318-27.
  • Salvi P, Parati G. Arterial stiffness and renal function—a complex relationship. Nat Rev Nephrol 2015; 11: 11-3.
  • Mitchell GF. Arterial stiffness and hypertension. Hypertension 2014; 64: 13-8.
  • Vlachopoulos C, Xaplanteris P, Aboyans V, et al. The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. Atherosclerosis 2015; 241: 507-32.
  • Zanoli L, Empana J-P, Perier M-C, et al. Increased carotid stiffness and remodelling at early stages of chronic kidney disease. J Hypertens 2019; 37: 1176-82.
  • Nemcsik J, Kiss I, Tislér A. Arterial stiffness, vascular calcification and bone metabolism in chronic kidney disease. World J Nephrol 2012; 1: 25.
  • McIntyre NJ, Fluck RJ, McIntyre CW, Fakis A, Taal MW. Determinants of arterial stiffness in chronic kidney disease stage 3. PLoS One 2013; 8: e55444.
  • Verhave JC, Fesler P, Du Cailar G, Ribstein J, Safar ME, Mimran A. Elevated pulse pressure is associated with low renal function in elderly patients with isolated systolic hypertension. Hypertension 2005; 45: 586-91.
  • Cesana F, Giannattasio C, Nava S, et al. Impact of blood glucose variability on carotid artery intima media thickness and distensibility in type 1 diabetes mellitus. Blood Pressure 2013; 22: 355-61.
  • Baykara S, Bozdağ PG, Baykara M, Namlı MN. Evaluation of arterial stiffness in patients with schizophrenia. J Clin Neurosci 2020; 79: 149-53.
  • Sarıca MA, İmam S. Cilostazol decreased carotid arterial stiffness and increased vertebral arterial flows in patient with peripheral arterial. Ann Vasc Med Res 2016; 3: 1034.
Toplam 26 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Orijinal Makale
Yazarlar

Kamil Doğan 0000-0002-8558-6295

Murat Baykara 0000-0003-2588-9013

Cansu Öztürk 0000-0003-3659-5184

Yayımlanma Tarihi 27 Mart 2023
Yayımlandığı Sayı Yıl 2023 Cilt: 6 Sayı: 2

Kaynak Göster

AMA Doğan K, Baykara M, Öztürk C. A comparative study of the effects of chronic kidney disease on sonographic arterial stiffness parameters in geriatric and normal population. J Health Sci Med /JHSM /jhsm. Mart 2023;6(2):294-299. doi:10.32322/jhsm.1226744

Üniversitelerarası Kurul (ÜAK) Eşdeğerliği:  Ulakbim TR Dizin'de olan dergilerde yayımlanan makale [10 PUAN] ve 1a, b, c hariç  uluslararası indekslerde (1d) olan dergilerde yayımlanan makale [5 PUAN]

Dahil olduğumuz İndeksler (Dizinler) ve Platformlar sayfanın en altındadır.

Not:
Dergimiz WOS indeksli değildir ve bu nedenle Q olarak sınıflandırılmamıştır.

Yüksek Öğretim Kurumu (YÖK) kriterlerine göre yağmacı/şüpheli dergiler hakkındaki kararları ile yazar aydınlatma metni ve dergi ücretlendirme politikasını tarayıcınızdan indirebilirsiniz. https://dergipark.org.tr/tr/journal/2316/file/4905/show 


Dergi Dizin ve Platformları

Dizinler; ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, vs.

Platformlar; Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons vs.